Table 3.
Changes in Parameters From Before to 6 Months After Cell Implantation
| Screening | 6 months | P value | |
|---|---|---|---|
| LVEF (%) | 29.2±7.6 | 28.4±9.8 | 0.5 |
| LVEDV (mL) | 180.4±50.8 | 186.0±25.6 | 0.5 |
| LVESV (mL) | 130.4±47.5 | 135.0±34.2 | 0.5 |
| BNP (pg/mL) | 330.6±290.6 | 302.8±324.9 | 0.59 |
| Troponin I (pg/mL)A | 47.3±20.4 | 42.6±15.5 | 0.63 |
| Peak V̇O2 (mL·min−1·kg−1) | 17.4±4.8 | 17.3±4.6 | 0.56 |
| Body weight (kg) | 61.2±9.9 | 62.5±11.0 | 0.22 |
| Skeletal muscle mass | 24.9±4.1 | 25.1±4.2 | 0.31 |
| Body fat mass | 15.2±4.6 | 16.0±4.3 | 0.41 |
| Pulse wave velocity (cm/s) | |||
| Right | 1,631.6±534.6 | 1,431.0±276.0 | 0.84 |
| Left | 1,621.8±547.1 | 1,433.0±299.1 | 0.78 |
Unless indicated otherwise, data are presented as the mean±SD. ATwo patients had troponin I concentrations <10 pg/mL (both before and after cell delivery). Therefore, data are shown for 3 patients. LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume.